Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedNov 13, 2013RopiniroleCross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming...Sandoz, Inc · D-66458-1Class IITerminatedNov 13, 2013Irinotecan Hydrochloride InjectionSuperpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will...West-Ward Pharmaceutical Corp. · D-66447-002Class IITerminatedNov 13, 2013Irinotecan Hydrochloride InjectionSuperpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will...West-Ward Pharmaceutical Corp. · D-66447-001Class IITerminatedNov 13, 2013Amlodipine Besylate TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-012Class IITerminatedNov 13, 2013Ciprofloxacin TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-011Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-010Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-009Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-008Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-007Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-006Class IITerminatedNov 13, 2013Amlodipine Besylate TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-005Class IITerminatedNov 13, 2013Ciprofloxacin TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-004Class IITerminatedNov 13, 2013Lamotrigine TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-003Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-002Class IITerminatedNov 13, 2013Amlodipine Besylate TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-001Class IITerminatedNov 13, 2013Prolia (denosumab) InjectionPresence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.Amgen, Inc. · D-66318-001Class IITerminatedNov 13, 2013Extended Phenytoin Sodium CapsulesFailed dissolution specifications; 18 month CRTAmneal Pharmaceuticals of New York, LLC. · D-66014-001Class IITerminatedNov 6, 2013Bevacizumab 25mg/mLLack of Assurance of Sterility: Fallon Pharmacy recalled Bevacizumab 25mg/mL due to sterility assurance concerns based on testing of this lot by a third party lab...Fallon Wellness Pharmacy Llc · D-66200-001Class IITerminatedOct 30, 2013Albuterol Sulfate Inhalation SolutionLack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic aseptic process simulation and discovered bacterial growth in a number...Nephron Pharmaceuticals Corp. · D-66462-001Class IIITerminatedOct 30, 2013Ketoconazole ShampooSubpotentTolmar, Inc. · D-66402-001Class IIITerminatedOct 30, 2013GILTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANTSubpotent; phenylephrine HClHi-Tech Pharmacal Co., Inc. · D-66207-001Class IITerminatedOct 23, 2013Concentrated MotrinPresence of Foreign Substance: process-related particulates which may be associated with the raw materials were observedMcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. · D-66272-001Class IIITerminatedOct 16, 2013Hydroxychloroquine Sulfate TabletsFailed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.Sandoz Incorporated · D-66373-001Class IITerminatedOct 16, 2013Next Choice" One Dose Emergency ContraceptiveFailed Tablet/Capsule Specifications: Multiple complaints for push through tablet breakage.Watson Laboratories Inc · D-66360-001Class IITerminatedOct 16, 20130.5% Bupivacaine HCl and Epinephrine 1:200Lack of Assurance of Sterility; potential for vial breakageHospira Inc. · D-66295-001Class IITerminatedOct 9, 2013Oxycodone and Acetaminophen TabletsPresence of Foreign Tablets/Capsules: 20 tablets of Oxycodone/APAP 7.5/500 mg were found in a sealed 100 count bottle of Oxycodone and Acetaminophen Tablets, USP 10/650...Watson Laboratories Inc · D-66251-001Class IITerminatedOct 9, 2013SIH-Testosterone Cypionate 200 mg/mL InjectableLack of Assurance of Sterility: concerns of sterility assurance with the pharmacy's independent testing laboratoryApothecary Shoppe · D-66241-002Class IITerminatedOct 9, 2013Estradiol 1.25 mgLack of Assurance of Sterility: concerns of sterility assurance with the pharmacy's independent testing laboratory.Apothecary Shoppe · D-66241-001Class IITerminatedOct 9, 20135% Lidocaine HCl and 7.5% Dextrose InjectionPresence of Particulate Matter; report of visible particulates in the glass ampuleHospira Inc. · D-66201-001Class IITerminatedOct 9, 2013HistamineLack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was...Triangle Compounding · D-1069-2013Class IITerminatedOct 9, 2013Sodium Phosphate InjectableLack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was...Triangle Compounding · D-1068-2013Class IIITerminatedOct 9, 2013VenlafaxineFailed Dissolution Specification:12 hour time point at 18 months of product shelf life.Osmotica Pharmaceutical Corp · D-1067-2013Class IITerminatedOct 9, 2013Ifosfamide Injection 3g/60 mLTemperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.AmeriSource Bergen · D-1066-2013Class IITerminatedOct 9, 2013Ifosfamide Injection 1g/20mLTemperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.AmeriSource Bergen · D-1065-2013Class IITerminatedOct 9, 2013Acetaminophen TabletsCGMP Deviations: The recalled acetaminophen tablet lot was not manufactured under current good manufacturing practices as noted by a recent inspection of the...Marlex Pharmaceuticals, Inc. · D-1064-2013Class IITerminatedOct 2, 2013Walgreens Progesterone in Ethyl Oleate 50 mg per mL InjectionLack of Assurance of Sterility: Walgreens Specialty Pharmacy is recalling one lot of Progesterone in Ethyl Oleate sterile injection due to concerns of sterility...Walgreens Co · D-1063-2013Class IITerminatedOct 2, 2013Pyridostigmine Bromide Tablets 60 mgFailed Stability Specifications: Pyridostigmine Bromide tablets, is being recalled due to an out of specification test result during stablity testing.Core Pharma Llc · D-1062-2013Class IIITerminatedSep 25, 2013Hydrocodone Bitartrate and Acetaminophen TabletsDefective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened...Watson Laboratories Inc · D-1061-2013Class IITerminatedSep 25, 2013Hydroxocobalamin MDV 5 mg/mLLack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab...Northern New England Compounding Pharmacy LLC · D-1060-2013Class IITerminatedSep 25, 2013Vancomycin PFLack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's...Avella of Deer Valley, Inc. · D-1059-2013